Mistletoe Clinical Trial
Now closed to enrollment. Full.
Believe Big is excited to be in the trenches with cancer research. We are supporting Johns Hopkins University School of Medicine to develop the first clinical trial in the United States using intravenous Mistletoe. This clinical trial brings together the conventional and complementary medical communities to fight cancer.
Mistletoe treatment for cancer is used widely in Germany and Switzerland, but in the United States, every potential treatment must be studied in a series of steps, called phases. Each phase is designed to answer a separate research question. The Mistletoe clinical trial at Johns Hopkins will be a Phase 1 trial, in which researchers will be testing the drug on a small group of participants to evaluate safety, determine a safe dose, and identify side effects. This is the first step of many research steps before mistletoe can be considered for conventional use in cancer treatment.
To find out more about Mistletoe in science and medicine click here.
FDA Required Disclaimer For Sites That Do Not Endorse Chemotherapy:
This web site is for educational purposes only. It is not intended as a substitute for the diagnosis, treatment and advice of a qualified licensed professional. This site offers people medical information beyond conventional medical options, but in no way should anyone consider that this site represents the “practice of medicine.” This site assumes no responsibility for how this material is used. Also note that this website frequently updates its contents, due to a variety of reasons, therefore, some information may be out of date. The statements regarding medical information beyond conventional treatments for cancer have not been evaluated by the FDA